Skip to content

EFFECTIVENESS OF HOMOEOPATHIC MEDICINES IN CHRONIC RHINOSINUSITIS

A RANDOMISED COMPARATIVE STUDY TO COMPARE THE EFFECTIVENESS OF INDIVIDUALISED HOMOEOPATHIC MEDICINE IN CENTESIMAL VERSUS FIFTY MILLESIMAL SCALE IN THE MANAGEMENT OF CHRONIC RHINOSINUSITIS - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/079853
Enrollment
60
Registered
2025-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Intervention1: Individualised Homoeopathic Medicine: Medicine should be given in Centesimal.Mode of administration is oral.Duration of intervention is 1 year.Dose should be given 4-6 globules Potency

Sponsors

Dr Aruma Prakash
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing to provide written informed consent. 2.Patients of both sexes in age groups between 18-70 years. 3.Patients having chronic sinusitis since 12weeks or more 4.Patients who have not taken any treatment since last 2wks for chronic sinusitis.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from other uncontrolled systemic diseases like cancer, uncontrolled infections or any vital organ failures. 2.Patients suffering from chronic sinusitis complications 3.Psychiatrically unstable patients. 4.Pregnant or lactating females. 5.Immunocompromised patients. 6.Significant renal impairment 7.Severe deviated nasal septum,patients having severe anatomical abnormalities of nose 8.Patients who are terminally ill, under immunosuppressive treatment or self reported immunocompromised state. 9.Diagnosed case of mental illness/psychiatric/life threatening illness affecting quality of life/any organ failure. 10.Substance abuse and/or dependance 11.Patients who are unwilling to take part or not giving consent to join the study or unable to read patient information

Design outcomes

Primary

MeasureTime frame
Primary outcome of treatment will be assessed by considering symptomatic improvement of the patient and X ray before and after treatmentTimepoint: One at baseline,in 6 months and in the end of the study.

Secondary

MeasureTime frame
Will be assessed using Chronic Sinusitis Assesment ScoreTimepoint: Assess at an interval of one month till completion of study

Countries

India

Contacts

Public ContactDr Aruma Prakash

Nehru Homoeopathic Medical College and Hospital

rashmichowdhry62@gmail.com9818366119

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026